Proton beam radiotherapy for uveal melanoma

References

• Shields JA, Augsburger JJ, Dougherty MJ. Orbital recurrence of choroidal melanoma 20 years after enucleation. Am J Ophthalmol. 1984;97:767–770.
   PubMed Web of Science ®Google Scholar
• Finger PT, Tena LB, Semenova E, et al. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit. Brachytherapy. 2014;13:275–280.
   PubMed Web of Science ®Google Scholar
• Moore RF. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol. 1930;14(4):145–152.
   PubMedGoogle Scholar
• Stallard HB. Radiotherapy of malignant intra-ocular neoplasms. Br J Ophthalmol. 1948;32(9):618–639.
   PubMed Web of Science ®Google Scholar
• Sealy R, Le Roux PL, Rapley F, et al. The treatment of ophthalmic tumours with low-energy sources. Br J Radiol. 1976;49(582):551–554.
   PubMed Web of Science ®Google Scholar
• Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology. 1980;87(6):582–590.
   PubMed Web of Science ®Google Scholar
• Lommatzsch P. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators. Surv Ophthalmol. 1974;19(2):85–100.
   PubMedGoogle Scholar
• Straatsma BR, Fine SL, Earle JD, et al. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology. 1988;95(7):1000–1004.
   PubMed Web of Science ®Google Scholar
• Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119:969–982.
   PubMedGoogle Scholar
• Gragoudas ES, Seddon J, Goitein M, et al. Current results of proton beam irradiation of uveal melanomas. Ophthalmology. 1985;92:284–291.
   PubMed Web of Science ®Google Scholar
• Char DH, Kroll SM, Castri J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125:81–89.
   PubMed Web of Science ®Google Scholar
• Mishra KK, Quivey JM, Daftari IK, et al. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma. Int J Radiat Oncol Biol Phys. 2015;92(2):376–383.
   PubMed Web of Science ®Google Scholar
• Hirasawa N, Tsuji H, Ishikawa H, et al Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2007;67(2):538–543.
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Lane AM, Kim AK. Charged-Particle Irradiation of Uveal Melanoma. In: Ryan SJ, editor. Retina. Vol. 3. 5th ed. London: Elsevier; 2013. p. 2290–2297.
   Google Scholar
• Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clinics. 2006;46(1):95–107.
   PubMedGoogle Scholar
• Damato B, Groenewald C, McGalliard J, et al. Endoresection of choroidal melanoma. Br J Ophthalmol. 1998;82(3):213–218.
   PubMed Web of Science ®Google Scholar
• Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92(8):1013–1014.
   PubMed Web of Science ®Google Scholar
• Konstantinidis L, Groenewald C, Coupland SE, et al. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol. 2014;98:82–85.
   PubMed Web of Science ®Google Scholar
• Damato BE, Stewart JM, Afshar AR, et al. Surgical resection of choroidal melanoma. In: Ryan SJ, editor. Retina, 6th ed. Vol. 3. London: Elsevier; 2016. In Press.
   Google Scholar
• McCannel TA Iodine-125 brachytherapy for extra-large choroidal melanomas: benefit of vitrectomy and silicone oil on visual acuity. Presented at the American Society of Retinal Specialists Annual Meeting; 2015 July 13; Vienna, Austria.
   Google Scholar
• McCannel TA, McCannel CA. Iodine 125 brachytherapy with vitrectromy and silincone oil in the treatment of uveal melanoma: a 1-to-1 matched case-control series. Int J Radiat Oncol Biol Phys. 2014;89(2):347–352.
   PubMed Web of Science ®Google Scholar
• Oliver SC, Leu MY, DeMarco JJ, et al Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma. Arch Ophthalmol. 2010;128(7):888–893.
   PubMedGoogle Scholar
• Ahuja Y 1, Kapoor KG, Thomson RM, et al. The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series. Eye (Lond). 2012 Nov;26(11):1487–1489.
   PubMed Web of Science ®Google Scholar
• Damato B, Heimann H. Personalized treatment of uveal melanoma. Eye (Lond). 2013;27(2):172–179.
   PubMed Web of Science ®Google Scholar
• Seider MI, Damato BE. Digital audio recording of initial patient visits to an ocular oncology clinic: a pilot study. Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):597–599.
   PubMed Web of Science ®Google Scholar
• Damato B, Eleuteri A, Taktak AF, et al Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–295.
   PubMed Web of Science ®Google Scholar
• Kivela T, Kujala E. Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye (Lond). 2013;27:243–252.
   PubMed Web of Science ®Google Scholar
• Kujala E, Damato B, Coupland SE, et al. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31:2825–2831.
   PubMed Web of Science ®Google Scholar
• Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222–1225.
   PubMed Web of Science ®Google Scholar
• Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience.Ophthalmology.2007;114:1925–1931
   PubMed Web of Science ®Google Scholar
• Damato B, Dopierala J, Klaasen A, et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci. 2009;50:3048–3055.
   PubMed Web of Science ®Google Scholar
• Homig-Holzel C, Savola S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol. 2012;21:189–206.
   PubMedGoogle Scholar
• Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44:1008–1011.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Chen R. The decisiondx-um gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr. 2013;9:5.
   Google Scholar
• Petousis V, Finger PT, Milman T. Anterior segment tumor biopsy using an aspiration cutter technique: clinical experience. Am J Ophthalmol. 2011 Nov;152(5):771-5.e1.
   Web of Science ®Google Scholar
• Goitein M, Miller T. Planning proton therapy of the eye. Med. Physics. 1983;10:275–283.
   PubMed Web of Science ®Google Scholar
• Zografos L, Perret C, Egger E, et al. Proton beam irradiation of uveal melanomas at Paul Scherrer Institute (former SIN). Strahlenther Onkol. 1990;166:114.
   Google Scholar
• Sheen MA. Proceedings of the 20th PTCOG Meeting, Vol. 10; Chester, England, 1994, pp. 16–18.
   Google Scholar
• Konstantinidis L, Roberts D, Errington RD, et al. Whole anterior segment proton beam radiotherapy for diffuse iris melanoma. Br J Ophthalmol. 2013;97:471–474.
   PubMed Web of Science ®Google Scholar
• Sharkawi E, Oleszczuk JD, Bergin C, et al. Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Br J Ophthalmol. 2012;96:1104–1107.
   PubMed Web of Science ®Google Scholar
• Tan AN, Hoevenaars JG, Webers CA, et al. Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Clin Ophthalmol. 2010;4:407–409.
   PubMedGoogle Scholar
• Konstantinidis L, Roberts D, Errington RD, et al Transpalpebral proton beam radiotherapy of choroidal melanoma. Br J Ophthalmol. 2015;99(2):232–235.
   PubMed Web of Science ®Google Scholar
• Marshall E, Romaniuk C, Ghaneh P, et al MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97(2):159–163.
   PubMed Web of Science ®Google Scholar
• Damato B, Eleuteri A, Fisher AC,et al. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.Ophthalmology.2008;115:1598–1607
   PubMedGoogle Scholar
• Eleuteri A, Damato B, Coupland SE, et al. Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. Int J Biomed Eng Technol. 2012;8:18–35.
   Google Scholar
• Field MG, Harbour JW. Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol. 2014 May;25(3):234–239.
   PubMed Web of Science ®Google Scholar
• Damato B, Kacperek A, Chopra M, et al. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005;62(5):1405–1411.
   PubMed Web of Science ®Google Scholar
• Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control with and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001;51:138–147.
   PubMed Web of Science ®Google Scholar
• Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65:780–787.
   PubMed Web of Science ®Google Scholar
• Gragoudas E, Li W, Goitein M, et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002;120:1665–1671.
   PubMed Web of Science ®Google Scholar
• Marucci L, Ancukiewicz M, Lane AM, et al Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys. 2011;79(3):842–846.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987;94:354–361.
   PubMed Web of Science ®Google Scholar
• Lane AM, Kim IK, Gragoudas ES. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011;129(9):1127–1130.
   PubMedGoogle Scholar
• Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond). 2013;27(2):163–171.
   PubMed Web of Science ®Google Scholar
• Damato B. Vasculopathy after treatment of choroidal melanoma. In: Joussen A, Gardner TW, Kirchhof B, et al., editors. Retinal vascular disease. Berlin: Springer; 2007. p. 582–591.
   Google Scholar
• Trichopoulos N, Damato B. Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma. Graefes Arch Clin Exp Ophthalmol. 2007;245(10):1573–1575.
   PubMed Web of Science ®Google Scholar
• Egger E, Zografos L, Schalenbourg A, et al Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 2003;55(4):867–880.
   PubMed Web of Science ®Google Scholar
• Egan K, Gragoudas E, Seddon J, et al The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989;96:1377–1383.
   PubMed Web of Science ®Google Scholar
• Egan K, Ryan L, Gragoudas E. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol. 1998;116:366–370.
   PubMedGoogle Scholar
• Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111:977–983.
   PubMed Web of Science ®Google Scholar
• Mishra KK, Daftari IK, Weinberg V. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume paramaters. Int J Radiat Oncol Biol Phys. 2013;87(2):330–336.
   PubMed Web of Science ®Google Scholar
• Mruthyunjaya P Peripheral retinal perfusion correlates with radiation retinopathy status following i-125 brachytherapy for uveal melanoma. American Society of Retinal Specialists Annual Meeting; 2015 Jul 13. Vienna, Austria.
   Google Scholar
• Yeung SN, Paton KE, Waite C, et al. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma. Can J Ophthalmol. 2010;45(3):269–273.
   PubMed Web of Science ®Google Scholar
• Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39(5):997–1010.
   PubMed Web of Science ®Google Scholar
• Group TCOMS. The collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2004;138:936–951.
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Lane AM. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am. 2005;18(1):111–118.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine. 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12):1684–1693.
   PubMedGoogle Scholar
• Shields CL, Kaliki S, Shah SU, et al Iris melanoma: features and prognosis in 317 children and adults. J Aapos. 2012;16(1):10–16.
   PubMed Web of Science ®Google Scholar
• Group COMS. Quality of life assessment in the collaborative ocular melanoma study. Design and methods. COMS-QOLS Report No 1. COMS Quality of Life Study Group. Ophthalmic Epidemiol. 1999;6:5–17.
   PubMedGoogle Scholar
• Brandberg Y, Damato B, Kivela¨ T, et al. EORTC ophthalmic oncology task force; EORTC Quality of Life Group. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (phase I-III). Eye (Lond). 2004;18:283–289.
   PubMed Web of Science ®Google Scholar
• Schevchenko L, Aarberg T Aflibercept for radiation retinopathy. Presented at the American Society of Retinal Specialists Annual Meeting; 2015 Jul 11. Vienna, Austria.
   Google Scholar
• Bui KM, Chow CC, Mieler WF. Treatment of recalcitrant radiation maculopathy using intravitreal dexamethasone (Ozurdex) implant. Summer Retin Cases Brief Rep. 2014;8(3):167–170.
   PubMedGoogle Scholar